• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性粒细胞白血病的急变期]

[Blast crisis in chronic myeloid leukemia].

作者信息

Fink R, Höche D, Wutke K

出版信息

Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(4):517-25.

PMID:6196268
Abstract

Although the worst prognosis among acute forms of leukemia is persistently attributed to the blast crisis of chronic myeloid leukemia, a therapeutic nihilism seems to us to be unreasonable. Even in the developing stage of a blast crisis we consider an aggressive chemotherapy to be justified particularly in younger patients. In this connection, value and necessity of supporting of therapy are especially emphasized. Remissions can be achieved in about one third of patients during the blast crisis of CML. As in other forms of tumour therapy, the initial status, age, and secondary diseases have to be taken into account and a careful, individual therapy planning has to be made. For the future there is the hope that the increasing possibilities of differentiating blasts will allow more systematic therapeutic conclusions to be made. According to the present knowledge the greatest hopes for achieving long-term remissions or even healings can, in our opinion, be expected by bone-marrow transplantation.

摘要

尽管急性白血病最糟糕的预后一直被认为是慢性粒细胞白血病的急变期所致,但在我们看来,治疗上的虚无主义是不合理的。即使在急变期的发展阶段,我们认为积极的化疗对于年轻患者尤其合理。在这方面,尤其强调支持治疗的价值和必要性。在慢性粒细胞白血病急变期,约三分之一的患者能够实现缓解。与其他肿瘤治疗形式一样,必须考虑初始状态、年龄和继发性疾病,并进行细致的个体化治疗规划。未来有望通过增加使原始细胞分化的可能性得出更系统的治疗结论。根据目前的知识,我们认为,实现长期缓解甚至治愈的最大希望在于骨髓移植。

相似文献

1
[Blast crisis in chronic myeloid leukemia].[慢性粒细胞白血病的急变期]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(4):517-25.
2
Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.长春地辛-泼尼松治疗慢性髓性白血病急变期
Cancer Treat Rep. 1985 Feb;69(2):203-4.
3
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.伊马替尼联合米托蒽醌/依托泊苷及阿糖胞苷是治疗慢性髓性白血病髓系原始细胞危象患者的一种有效诱导疗法。
Cancer. 2007 Apr 15;109(8):1543-9. doi: 10.1002/cncr.22535.
4
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.使用600毫克伊马替尼治疗的急变期慢性髓性白血病:6年随访后存活患者的结局
Haematologica. 2008 Dec;93(12):1792-6. doi: 10.3324/haematol.13068. Epub 2008 Oct 6.
5
Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.采用5'-肌苷酸脱氢酶活性的选择性阻断剂替唑呋林对难治性白血病及慢性粒细胞白血病髓系原始细胞危象进行生化靶向治疗。
Anticancer Res. 1996 Nov-Dec;16(6A):3341-7.
6
Blast crisis in chronic myeloid leukaemia.慢性髓性白血病的急变期
J Assoc Physicians India. 1987 Feb;35(2):127-9.
7
[Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].STI571治疗慢性髓性白血病患者的临床疗效及副作用
Ai Zheng. 2004 Apr;23(4):421-5.
8
[Blast crisis in chronic myeloid leukemia. Results with vindesine and prednisolone].[慢性髓性白血病的急变期。长春地辛与泼尼松龙的治疗结果]
Dtsch Med Wochenschr. 1985 Dec 13;110(50):1936-9. doi: 10.1055/s-2008-1069116.
9
Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.淋巴母细胞期慢性髓性白血病:特征、治疗反应及预后
Am J Med. 1993 Jan;94(1):69-74.
10
The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.联合治疗在伴有中枢神经系统受累的成人急性髓系白血病中的价值。
Haematologica. 1997 Sep-Oct;82(5):577-80.